Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-11-22

FDA Approved: QUETIAPINE — Supplemental Application (Accord Healthcare Inc.)

View source ↗

Summary

FDA approves a supplemental application for Quetiapine by Accord Healthcare Inc., granting regulatory approval for a generic version of the antipsychotic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Quetiapine (quetiapine)

Snippet

SUPPL AP for QUETIAPINE (QUETIAPINE)